- /
- Supported exchanges
- / US
- / THAR.NASDAQ
Tharimmune Inc. (THAR NASDAQ) stock market data APIs
Tharimmune Inc. Financial Data Overview
Tharimmune, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. It is also involved in the clinical-stage biotech research and development activities. The company was formerly known as Hillstream BioPharma, Inc. and changed its name to Tharimmune, Inc. in September 2023. Tharimmune, Inc. was founded in 2017 and is based in Red Bank, New Jersey.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Tharimmune Inc. (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Tharimmune Inc. data using free add-ons & libraries
Get Tharimmune Inc. Fundamental Data
Tharimmune Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tharimmune Inc. News
New
Crypto Treasury Companies Are Chasing Obscure Tokens—And That's Raising Red Flags About Market Volatility
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. As Bitcoin’s shine dulls and market saturation squeezes returns, a new breed of publicly traded ...
New Crypto Deals Put Retail at Risk After $17 Billion Wipeout
(Bloomberg) -- Executives are turning to a novel structure to fund crypto accumulation vehicles as investor appetite thins. They’re called in-kind contributions, and they now account for a growing ...
Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy
Nasdaq-listed Tharimmune (THAR) has raised about $540 million in a private placement led by DRW and Liberty City Ventures, as the biotech firm pivots toward a digital asset treasury (DAT) strategy cen...
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
RED BANK, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tharimmune, Inc. (Nasdaq: THAR), a clinical-stage biotechnology company dedicated to developing innovative therapeutic candidates for inflammation,...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.